The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Background The recent emergence of COVID-19, rapid worldwide spread, and incomplete
knowledge of molecular mechanisms underlying SARS-CoV-2 infection have limited …

Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology …

Pathogenesis SARS-CoV-2 spreads through respiratory droplet transmission as well as
contaminated objects or surfaces and enters host cells via the functional cell receptor ACE2 …

Long-term analyses of demographical and clinical characteristics of COVID-19 patients can
provide a better overview of the clinical course of the disease. They can also help …

Abstract Background During COVID‐19 outbreak, Italy was the first country in Europe to be
heavily affected with an intensive care unit mortality of 26%. In order to reduce this …

The COVID-19 pandemic caused by SARS-CoV-2 infection has been of unprecedented
clinical and socio-economic worldwide relevance. The case fatality rate for COVID-19 grows …

Abstract Coronavirus disease 2019 (COVID-19) is a pandemic syndrome caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection …

Purpose The pathogenesis of coronavirus disease 2019 (COVID-19) is complicated, and in
addition to antiviral therapy and combating coagulopathy, treatment should also include …